AMBA
Ambarella, Inc.
AMBA's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over AMBA overall, supported by stronger valuation and stronger modeled upside.
AMBA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
AMBA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
AMBA PE Valuation
AMBA has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
AMBA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMBA has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
AMBA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.96 | — |
| Q3 2026 | -$1.29 | +$0.82 |
| Q2 2026 | -$1.61 | +$0.88 |
| Q1 2026 | -$1.78 | +$1.06 |
| Q4 2025 | -$1.88 | +$1.99 |
| Q3 2025 | -$2.11 | +$2.22 |
| Q2 2025 | -$2.49 | +$1.78 |
| Q1 2025 | -$2.84 | +$1.41 |
| Q4 2024 | -$3.87 | -$0.85 |
AMBA is still losing money, but far less than before: $1.29 per share over the past year, against $4.33 at its worst in mid-2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over AMBA on earnings quality, reporting a profit while its opponent remains loss making.
AMBA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $108.1M | +13% |
| Q2 2026 | $100.4M | +17% |
| Q1 2026 | $100.9M | +20% |
| Q4 2025 | $108.5M | +31% |
| Q3 2025 | $95.5M | +50% |
| Q2 2025 | $85.9M | +58% |
| Q1 2025 | $84M | +63% |
| Q4 2024 | $82.7M | +63% |
AMBA's revenue has grown year over year for nine quarters in a row: $108M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.5% | +16 points |
| Q2 2026 | -19% | +11 points |
| Q1 2026 | -18% | +12 points |
| Q4 2025 | -15% | +16 points |
| Q3 2025 | -23% | +34 points |
| Q2 2025 | -30% | +42 points |
| Q1 2025 | -30% | +51 points |
| Q4 2024 | -31% | +52 points |
AMBA's operating margin was −7.5% last quarter, up 15 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over AMBA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over AMBA on profitability, with a higher operating margin.
AMBA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.1M | -612% |
| Q2 2026 | -$29.6M | -389% |
| Q1 2026 | $15M | -30% |
| Q4 2025 | $31.4M | +663% |
| Q3 2025 | $1.4M | -90% |
| Q2 2025 | $10.2M | +$26.3M |
| Q1 2025 | $21.2M | +$27.2M |
| Q4 2024 | $4.1M | -25% |
AMBA usually generates cash, though not every quarter: the latest was −$7M, but it generated $10M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over AMBA on cash flow, with more consistent year-over-year improvement.
AMBA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +400K shares |
| 1 year | +3.4% | +1.5M shares |
| 3 years | +11% | +4.3M shares |
| 5 years | +21% | +7.6M shares |
| Available history | +32% | +10.7M shares |
AMBA has 44M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.4M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $1M |
| Q1 2022 | — |
| Q4 2021 | — |
AMBA has spent almost nothing on buybacks in the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over AMBA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
AMBA Net Leverage
AMBA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMBA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.9 | Neutral |
| Stochastic | 16.2 | Oversold |
AMBA's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
AMBA PE vs Technology Sector
AMBA has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
AMBA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $65.0 | 6% below |
| 20 week MA | $70.1 | 13% below |
| 50 week MA | $67.7 | 9.9% below |
| 100 week MA | $68.1 | 10% below |
| 200 week MA | $65.2 | 6.4% below |
AMBA is in a downtrend: it's below all five of its weekly moving averages, and 6.4% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over AMBA on trend strength, trading above more of its moving averages.
AMBA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.9 | $92.6 | +55% |
| 2021 | $92.6 | $200.6 | +117% |
| 2022 | $200.6 | $81.2 | -60% |
| 2023 | $81.2 | $61.3 | -25% |
| 2024 | $61.3 | $73.5 | +20% |
| 2025 | $73.5 | $71.4 | -2.9% |
| 2026 YTD | $71.4 | $61.1 | -14% |
AMBA's yearly returns have swung widely, from +117% in 2021 to −60% in 2022. It's down 14% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over AMBA on returns for 2026, with the stronger performance.